Canadian Sec - Free Realtime Quote CAD

Optimi Health Corp. (OPTI.CN)

Compare
0.1950 -0.0050 (-2.50%)
As of 9:30 AM EST. Market Open.
Loading Chart for OPTI.CN
DELL
  • Previous Close 0.2000
  • Open 0.1950
  • Bid --
  • Ask 0.2000 x --
  • Day's Range 0.1950 - 0.1950
  • 52 Week Range 0.1500 - 0.5800
  • Volume 550
  • Avg. Volume 58,788
  • Market Cap (intraday) 18.459M
  • Beta (5Y Monthly) 1.28
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0600
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Optimi Health Corp. engages in the research, cultivation, processing, extraction, and distribution of psilocybin, psilocin, other psychedelic substances, and functional mushrooms for health and wellness markets in Canada and internationally. The company offers raw mushroom biomass, mushroom extracts, and mushroom supplements, as well as a range of fungi varieties, including Lion's Mane, Chaga, Reishi, Turkey Tail, and Cordyceps. It sells its products through www.optimilife.com, an e-commerce website platform; and Amazon marketplace, and distributors/brokers. The company was formerly known as 1251418 BC Ltd. and changed its name to Optimi Health Corp. in August 2020. Optimi Health Corp. was incorporated in 2020 and is based in Garibaldi Highlands, Canada.

www.optimihealth.ca

--

Full Time Employees

September 30

Fiscal Year Ends

Recent News: OPTI.CN

View More

Performance Overview: OPTI.CN

Trailing total returns as of 11/27/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

OPTI.CN
20.41%
S&P/TSX Composite index
21.62%

1-Year Return

OPTI.CN
18.18%
S&P/TSX Composite index
26.79%

3-Year Return

OPTI.CN
67.50%
S&P/TSX Composite index
20.65%

5-Year Return

OPTI.CN
75.63%
S&P/TSX Composite index
49.62%

Compare To: OPTI.CN

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: OPTI.CN

View More

Valuation Measures

Annual
As of 11/26/2024
  • Market Cap

    18.93M

  • Enterprise Value

    21.33M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    71.69

  • Price/Book (mrq)

    1.69

  • Enterprise Value/Revenue

    84.83

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -21.27%

  • Return on Equity (ttm)

    -45.46%

  • Revenue (ttm)

    351.92k

  • Net Income Avi to Common (ttm)

    -5.64M

  • Diluted EPS (ttm)

    -0.0600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    245.84k

  • Total Debt/Equity (mrq)

    25.26%

  • Levered Free Cash Flow (ttm)

    -3.1M

Research Analysis: OPTI.CN

View More

Company Insights: OPTI.CN

Research Reports: OPTI.CN

View More

People Also Watch